PIN1 Protein

PIN1 Protein
Compound	Type
Juglone	Inhibitor
PiB	Inhibitor
PIN1-Td	Inhibitor
Associated Diseases	ALZHEIMER'S DISEASE, Aging, Als, Alzheimer, Alzheimer's disease
KG Connections	102 edges

Introduction

Pin1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

PIN1 is a unique peptidyl-prolyl cis-trans isomerase (PPIase) that catalyzes the isomerization of specific phosphorylated serine/threonine-proline motifs in target proteins. This post-translational modification regulates protein function, localization, stability, and interactions, making PIN1 a critical regulator of signaling pathways involved in neurodegeneration [1]. ^{2**Activity enhancement**: For loss-of-function scenarios in ADActivity enhancement}

Overview

PIN1 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of PIN1 is associated with neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and related disorders. ^{3**Protein-protein interaction blockers**: Disrupt PIN1-substrate interactionsProtein-protein interaction blockers}

Structure

PIN1 is a 163-amino acid protein with a distinctive bipartite structure: ^{4PIN1 maint: Smet-Nocca C, et al2017}

• N-terminal WW domain: Recognizes phosphorylated serine/threonine-proline (pSer/Thr-Pro) motifs

• C-terminal PPIase domain: Catalyzes prolyl isomerization

This two-domain architecture allows PIN1 to act as a molecular timer, converting phosphorylation signals into conformational changes in target proteins. [^5]

Normal Function

Prolyl Isomerization

PIN1 catalyzes the cis-trans isomerization of peptide bonds preceding proline residues, particularly those that are phosphorylated. This conformational change can:

• Alter protein-protein interactions

• Change substrate localization

• Modify protein stability

• Activate or inhibit enzymatic activity

Cell Cycle Regulation

PIN1 is essential for cell cycle progression:

• Regulates cyclin-dependent kinase activity

• Controls entry into mitosis

• Modulates DNA damage responses

Transcription Regulation

PIN1 affects gene expression by:

• Modifying transcription factor activity

• Regulating co-activator function

• Controlling histone modifications

Role in Neurodegenerative Diseases

Alzheimer’s Disease

PIN1 dysfunction is closely linked to AD pathogenesis:

• Tau pathology: Loss of PIN1 function leads to increased tau aggregation and NFT formation

• Amyloid precursor protein (APP) processing: PIN1 regulates APP trafficking and Aβ production

• Synaptic dysfunction: Impaired synaptic plasticity and memory formation

• Neuronal cell cycle re-entry: Aberrant cell cycle activation in AD neurons

Genetic studies show PIN1 promoter polymorphisms increase AD risk [2].

Parkinson’s Disease

• α-Synuclein phosphorylation: PIN1 affects α-synuclein aggregation propensity

• Mitochondrial function: Modulates PINK1/Parkin pathway

• Dopaminergic neuron survival: Regulates neuronal viability

Amyotrophic Lateral SALS

• TDP-43 pathology: Alters TDP-43 phosphorylation and aggregation

• RNA processing: Dysregulation of RNA-binding proteins

Therapeutic Targeting

PIN1 Modulators

Therapeutic Approaches

Background

The study of Pin1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data

Key Publications

^{4PIN1 maint: Smet-Nocca C, et al2017}: Ghosh A, et al. PIN1 maint[^5]: Smet-Nocca C, et al. Identification of novel tau phosphorylation inhibitors. ChemMedChem. 2017;12(10):808-818. ^{1CitationPMID 28494182Open reference}(https:/

Cross-References

• Tau Pathology Alzheimer’s Disease

• [Parkinson’s Disease](/di- Alpha-Synucleinisease)

• Alpha-Synuclein APP

See Also

• Protein Isomerase Inhibitors

• Tau Pathology Pathway